These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 18066656
21. Nifedipine prevents hepatic fibrosis in a non-alcoholic steatohepatitis model induced by an L-methionine-and choline-deficient diet. Nakagami H, Shimamura M, Miyake T, Shimosato T, Minobe N, Moritani T, Kiomy Osako M, Nakagami F, Koriyama H, Kyutoku M, Shimizu H, Katsuya T, Morishita R. Mol Med Rep; 2012 Jan; 5(1):37-40. PubMed ID: 21946918 [Abstract] [Full Text] [Related]
22. Melatonin Attenuates Inflammation, Oxidative Stress, and DNA Damage in Mice with Nonalcoholic Steatohepatitis Induced by a Methionine- and Choline-Deficient Diet. Miguel FM, Picada JN, da Silva JB, Schemitt EG, Colares JR, Hartmann RM, Marroni CA, Marroni NP. Inflammation; 2022 Oct; 45(5):1968-1984. PubMed ID: 35419738 [Abstract] [Full Text] [Related]
23. Hepatoprotective effect of infliximab, an anti-TNF-alpha agent, on carbon tetrachloride-induced hepatic fibrosis. Bahcecioglu IH, Koca SS, Poyrazoglu OK, Yalniz M, Ozercan IH, Ustundag B, Sahin K, Dagli AF, Isik A. Inflammation; 2008 Aug; 31(4):215-21. PubMed ID: 18427963 [Abstract] [Full Text] [Related]
24. Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis. Zhang S, Wang J, Liu Q, Harnish DC. J Hepatol; 2009 Aug; 51(2):380-8. PubMed ID: 19501927 [Abstract] [Full Text] [Related]
25. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice. Csak T, Velayudham A, Hritz I, Petrasek J, Levin I, Lippai D, Catalano D, Mandrekar P, Dolganiuc A, Kurt-Jones E, Szabo G. Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G433-41. PubMed ID: 21233280 [Abstract] [Full Text] [Related]
26. Dandelion leaf extract protects against liver injury induced by methionine- and choline-deficient diet in mice. Davaatseren M, Hur HJ, Yang HJ, Hwang JT, Park JH, Kim HJ, Kim MS, Kim MJ, Kwon DY, Sung MJ. J Med Food; 2013 Jan; 16(1):26-33. PubMed ID: 23256442 [Abstract] [Full Text] [Related]
27. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice. Min AK, Kim MK, Kim HS, Seo HY, Lee KU, Kim JG, Park KG, Lee IK. Life Sci; 2012 Jan 30; 90(5-6):200-5. PubMed ID: 22154902 [Abstract] [Full Text] [Related]
28. Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies. Kirsch R, Clarkson V, Shephard EG, Marais DA, Jaffer MA, Woodburne VE, Kirsch RE, Hall Pde L. J Gastroenterol Hepatol; 2003 Nov 30; 18(11):1272-82. PubMed ID: 14535984 [Abstract] [Full Text] [Related]
29. n-3 polyunsaturated fatty acids worsen inflammation and fibrosis in experimental nonalcoholic steatohepatitis. Provenzano A, Milani S, Vizzutti F, Delogu W, Navari N, Novo E, Maggiora M, Maurino V, Laffi G, Parola M, Marra F. Liver Int; 2014 Jul 30; 34(6):918-30. PubMed ID: 24628836 [Abstract] [Full Text] [Related]
30. Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue. Kudo H, Yata Y, Takahara T, Kawai K, Nakayama Y, Kanayama M, Oya T, Morita S, Sasahara M, Mann DA, Sugiyama T. Liver Int; 2009 Aug 30; 29(7):988-96. PubMed ID: 19386026 [Abstract] [Full Text] [Related]
31. Methionine- and choline-deficient diet induces hepatic changes characteristic of non-alcoholic steatohepatitis. Marcolin E, Forgiarini LF, Tieppo J, Dias AS, Freitas LA, Marroni NP. Arq Gastroenterol; 2011 Aug 30; 48(1):72-9. PubMed ID: 21537547 [Abstract] [Full Text] [Related]
32. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. Matsumoto M, Hada N, Sakamaki Y, Uno A, Shiga T, Tanaka C, Ito T, Katsume A, Sudoh M. Int J Exp Pathol; 2013 Apr 30; 94(2):93-103. PubMed ID: 23305254 [Abstract] [Full Text] [Related]
33. Curcumin limits the fibrogenic evolution of experimental steatohepatitis. Vizzutti F, Provenzano A, Galastri S, Milani S, Delogu W, Novo E, Caligiuri A, Zamara E, Arena U, Laffi G, Parola M, Pinzani M, Marra F. Lab Invest; 2010 Jan 30; 90(1):104-15. PubMed ID: 19901911 [Abstract] [Full Text] [Related]
34. Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice. Nan YM, Fu N, Wu WJ, Liang BL, Wang RQ, Zhao SX, Zhao JM, Yu J. Scand J Gastroenterol; 2009 Jan 30; 44(3):358-65. PubMed ID: 18991162 [Abstract] [Full Text] [Related]
35. The pro-inflammatory action of tumour necrosis factor-α in non-alcoholic steatohepatitis is independent of the NSMAF gene product. Mas E, Danjoux M, Garcia V, Carpentier S, Ségui B, Levade T. Dig Liver Dis; 2013 Feb 30; 45(2):147-54. PubMed ID: 23044079 [Abstract] [Full Text] [Related]
36. Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet. Nagasawa T, Inada Y, Nakano S, Tamura T, Takahashi T, Maruyama K, Yamazaki Y, Kuroda J, Shibata N. Eur J Pharmacol; 2006 Apr 24; 536(1-2):182-91. PubMed ID: 16574099 [Abstract] [Full Text] [Related]
37. Visfatin exacerbates hepatic inflammation and fibrosis in a methionine-choline-deficient diet mouse model. Heo YJ, Choi SE, Lee N, Jeon JY, Han SJ, Kim DJ, Kang Y, Lee KW, Kim HJ. J Gastroenterol Hepatol; 2021 Sep 24; 36(9):2592-2600. PubMed ID: 33600604 [Abstract] [Full Text] [Related]
38. Modulatory role of Co-enzyme Q10 on methionine and choline deficient diet-induced non-alcoholic steatohepatitis (NASH) in albino rats. Saleh DO, Ahmed RF, Amin MM. Appl Physiol Nutr Metab; 2017 Mar 24; 42(3):243-249. PubMed ID: 28177750 [Abstract] [Full Text] [Related]
39. Danhe granule ameliorates nonalcoholic steatohepatitis and fibrosis in rats by inhibiting ceramide de novo synthesis related to CerS6 and CerK. Zhu M, Jia Z, Yan X, Liu L, Fang C, Feng M, Dai Y, Zhang Y, Wu H, Huang B, Li Y, Liu J, Xiao H. J Ethnopharmacol; 2022 Sep 15; 295():115427. PubMed ID: 35654350 [Abstract] [Full Text] [Related]
40. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis. Kitamura K, Tada S, Nakamoto N, Toda K, Horikawa H, Kurita S, Tsunematsu S, Kumagai N, Ishii H, Saito H, Hibi T. J Gastroenterol Hepatol; 2007 Nov 15; 22(11):2022-33. PubMed ID: 17914985 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]